Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial-Reference-Cited by-同舟云学术

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

Published:2016-10 Issue:10 Volume:3 Page:e463-e472
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Leth Steffen,Schleimann Mariane H,Nissen Sara K,Højen Jesper F,Olesen Rikke,Graversen Mette E,Jørgensen Sofie,Kjær Anne Sofie,Denton Paul W,Mørk Alejandra,Sommerfelt Maja A,Krogsgaard Kim,Østergaard Lars,Rasmussen Thomas A,Tolstrup Martin,Søgaard Ole Schmeltz

Funder

Research Council of Norway Global Health and Vaccination Research programme

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference27 articles.

1. Survival of persons with and without HIV infection in Denmark, 1995–2005;Lohse;Ann Intern Med,2007

2. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency;Chun;Nat Med,1995

3. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys;Whitney;Nature,2014

4. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV;Folks;J Immunol,1986

5. HIV preferentially infects HIV-specific CD4+ T cells;Douek;Nature,2002

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the effect of HDAC inhibitors on the formation of the HIV reservoir;mBio;2024-09-11

2. Advancing Toward a Human Immunodeficiency Virus Cure;Infectious Disease Clinics of North America;2024-09

3. Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study;Cell Discovery;2024-05-14

4. Targeting Viral Transcription for HIV Cure Strategies;Microorganisms;2024-04-08

5. Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a;Cell;2024-02